Article Menu
- Academic Editor
- Subscribe SciFeed
- Recommended Articles
- Related Info Links
-
More by Authors Links
- on DOAJ
- Le Corre, N.
- Abarca, K.
- Astudillo, P.
- Potin, M.
- López, S.
- Goldsack, M.
- Valenzuela, V.
- Schilling, A.
- Gaete, V.
- Rubio, L.
- Calvo, M.
- Twele, L.
- González, M.
- Fuentes, D.
- Gutiérrez, V.
- Reyes, F.
- Tapia, L. I.
- Villena, R.
- Retamal-Díaz, A.
- Cárdenas, A.
- Alarcón-Bustamante, E.
- Meng, X.
- Xin, Q.
- González-Aramundiz, J. V.
- Álvarez-Figueroa, M. Javiera
- González, P. A.
- Bueno, S. M.
- Soto, J. A.
- on behalf of the PedCoronaVac03CL Study Group, .
- Perret, C.
- Kalergis, A. M.
- on Google Scholar
- Le Corre, N.
- Abarca, K.
- Astudillo, P.
- Potin, M.
- López, S.
- Goldsack, M.
- Valenzuela, V.
- Schilling, A.
- Gaete, V.
- Rubio, L.
- Calvo, M.
- Twele, L.
- González, M.
- Fuentes, D.
- Gutiérrez, V.
- Reyes, F.
- Tapia, L. I.
- Villena, R.
- Retamal-Díaz, A.
- Cárdenas, A.
- Alarcón-Bustamante, E.
- Meng, X.
- Xin, Q.
- González-Aramundiz, J. V.
- Álvarez-Figueroa, M. Javiera
- González, P. A.
- Bueno, S. M.
- Soto, J. A.
- on behalf of the PedCoronaVac03CL Study Group, .
- Perret, C.
- Kalergis, A. M.
- on PubMed
- Le Corre, N.
- Abarca, K.
- Astudillo, P.
- Potin, M.
- López, S.
- Goldsack, M.
- Valenzuela, V.
- Schilling, A.
- Gaete, V.
- Rubio, L.
- Calvo, M.
- Twele, L.
- González, M.
- Fuentes, D.
- Gutiérrez, V.
- Reyes, F.
- Tapia, L. I.
- Villena, R.
- Retamal-Díaz, A.
- Cárdenas, A.
- Alarcón-Bustamante, E.
- Meng, X.
- Xin, Q.
- González-Aramundiz, J. V.
- Álvarez-Figueroa, M. Javiera
- González, P. A.
- Bueno, S. M.
- Soto, J. A.
- on behalf of the PedCoronaVac03CL Study Group, .
- Perret, C.
- Kalergis, A. M.
Need Help?
Order Article Reprints
Journal: Vaccines, 2023
Volume: 11
Number: 1526
1526
Article:
Different Safety Pattern of an Inactivated SARS-CoV-2 Vaccine (CoronaVac®) According to Age Group in a Pediatric Population from 3 to 17 Years Old, in an Open-Label Study in Chile
Authors:
by
Nicole Le Corre, Katia Abarca, Patricio Astudillo, Marcela Potin, Sofía López, Macarena Goldsack, Vania Valenzuela, Andrea Schilling, Victoria Gaete, Lilian Rubio, Mario Calvo, Loreto Twele, Marcela González, Daniela Fuentes, Valentina Gutiérrez, Felipe Reyes, Lorena I. Tapia, Rodolfo Villena, Angello Retamal-Díaz, Antonio Cárdenas, Eduardo Alarcón-Bustamante, Xing Meng, Qianqian Xin, José V. González-Aramundiz, María Javiera Álvarez-Figueroa, Pablo A. González, Susan M. Bueno, Jorge A. Soto, on behalf of the PedCoronaVac03CL Study Group, Cecilia Perret and Alexis M. Kalergisadd
Show full author list
remove
Hide full author list
Link:
https://www.mdpi.com/2076-393X/11/10/1526
MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover
and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article
and designed to be complimentary to the journal.
Cite
Le Corre, N.; Abarca, K.; Astudillo, P.; Potin, M.; López, S.; Goldsack, M.; Valenzuela, V.; Schilling, A.; Gaete, V.; Rubio, L.; et al. Different Safety Pattern of an Inactivated SARS-CoV-2 Vaccine (CoronaVac®) According to Age Group in a Pediatric Population from 3 to 17 Years Old, in an Open-Label Study in Chile. Vaccines 2023, 11, 1526. https://doi.org/10.3390/vaccines11101526
Le Corre N, Abarca K, Astudillo P, Potin M, López S, Goldsack M, Valenzuela V, Schilling A, Gaete V, Rubio L, et al. Different Safety Pattern of an Inactivated SARS-CoV-2 Vaccine (CoronaVac®) According to Age Group in a Pediatric Population from 3 to 17 Years Old, in an Open-Label Study in Chile. Vaccines. 2023; 11(10):1526. https://doi.org/10.3390/vaccines11101526
Chicago/Turabian StyleLe Corre, Nicole, Katia Abarca, Patricio Astudillo, Marcela Potin, Sofía López, Macarena Goldsack, Vania Valenzuela, Andrea Schilling, Victoria Gaete, Lilian Rubio, and et al. 2023. "Different Safety Pattern of an Inactivated SARS-CoV-2 Vaccine (CoronaVac®) According to Age Group in a Pediatric Population from 3 to 17 Years Old, in an Open-Label Study in Chile" Vaccines 11, no. 10: 1526. https://doi.org/10.3390/vaccines11101526
APA StyleLe Corre, N., Abarca, K., Astudillo, P., Potin, M., López, S., Goldsack, M., Valenzuela, V., Schilling, A., Gaete, V., Rubio, L., Calvo, M., Twele, L., González, M., Fuentes, D., Gutiérrez, V., Reyes, F., Tapia, L. I., Villena, R., Retamal-Díaz, A., ... Kalergis, A. M. (2023). Different Safety Pattern of an Inactivated SARS-CoV-2 Vaccine (CoronaVac®) According to Age Group in a Pediatric Population from 3 to 17 Years Old, in an Open-Label Study in Chile. Vaccines, 11(10), 1526. https://doi.org/10.3390/vaccines11101526
